Medical laboratory scientist

ORBIS EDUCATION SERVICES TEAMS UP WITH SAINT LOUIS UNIVERSITY TO LAUNCH ACCELERATED BACHELOR OF SCIENCE IN MEDICAL LABORATORY SCIENCE

Retrieved on: 
Monday, April 25, 2022
ASCP, Occupational therapy, Society, CEO, Awareness, SLU, Scene (filmmaking), Saint Louis University, American Society for Clinical Pathology, Bureau of Labor Statistics, Catholic (term), COVID-19, National, Student, Diagnosis, Life, Medicine, Trauma, Hospital, Education, Sickle cell disease, Patient, Bureau, Blood, Activated sludge, Hematology, Saint Louis University (Philippines), Health, Medical laboratory scientist, Leukemia, Summer Science Program, Certification, Industry, University, Mississippi River, Orbis Education and Care, Veterinary medicine, Pharmaceutical industry, Society of Jesus, Program, Orbis

INDIANAPOLIS, April 25, 2022 /PRNewswire/ -- Medical Laboratory Scientists (MLSs) are the professionals that doctors and other medical providers rely on to make decisions about a patient's diagnosis, treatment and monitoring. But like other healthcare heroes, MLSs are in short supply.

Key Points: 
  • April 24 30 is Medical Laboratory Professionals Week, an opportunity to show appreciation for clinical laboratory personnel and raise awareness of a critical workforce shortage within the laboratory science industry.
  • "Medical laboratory scientists work behind the scenes, but they make a huge impact on patient care," said Elizabeth Gockel-Blessing, Ph.D., associate dean and associate professor of medical laboratory science in Saint Louis University's DoisyCollegeof Health Sciences.
  • Health care settings that offer medical laboratory testing are in dire need of qualified staff, said Daniel Briggs, founder and CEO of Orbis.
  • Saint Louis University's in-person medical laboratory science program was one of the first of its kind and has been accredited by the National Accrediting Agency for Clinical Laboratory Science for more than 85 years.

MediPharm Labs Names Experienced Pharma and Med Tech Executive David Pidduck, as CEO

Retrieved on: 
Wednesday, April 20, 2022
News, Board, CEO, Phrase, Business administration, MBA, Northwestern University, ISO, Medical laboratory scientist, Legislation, Wilfrid Laurier University, Research, Good, Organization, Medication, OTCQX, FSE, Failure, Company, Forward-looking statement, TSX, Multimedia, Industry, RSU, SEDAR, Bachelor of Business Administration, Cannabinoid, View, API, Fine chemical, Management, Pharma

BARRIE, ON, April 20, 2022 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs", "MediPharm" or the "Company") a pharmaceutical company specializing in precision-based cannabinoids, today announced that it has appointed experienced Pharma and Med Tech executive David Pidduck as Chief Executive Officer and Director of the Company.

Key Points: 
  • BARRIE, ON, April 20, 2022 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs", "MediPharm" or the "Company") a pharmaceutical company specializing in precision-based cannabinoids, today announced that it has appointed experienced Pharma and Med Tech executive David Pidduck as Chief Executive Officer and Director of the Company.
  • Chris Taves, Chairman of the Boardcommented, "We are very pleased to welcome David Pidduck to MediPharm.
  • With a strong background in business development, strategy, and M&A within the Pharma and Med Tech sectors, David is the right individual to lead the Company through this formative period.
  • Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.

LifeLabs and Anderson College Working Together to Support Medical Laboratory Technologist Careers

Retrieved on: 
Thursday, April 14, 2022
Anderson, MLT, Medical laboratory scientist, COVID-19, Life, Program, Anderson University, Advance for Medical Laboratory Professionals, OMERS, Student, Laboratory, United States national laboratories, Partnership, Business, Medicine, Technology

They will receive practical experience to supplement their classroom instruction and laboratory training at Anderson College.

Key Points: 
  • They will receive practical experience to supplement their classroom instruction and laboratory training at Anderson College.
  • "We are proud of this important collaboration between LifeLabs and Anderson College to deliver practical experience for new Medical Lab Technologists," said Haleh Bahrami, Vice President of Lab Operations at LifeLabs and a trained Medical Lab Technologist.
  • "By working together, Anderson College and LifeLabs are uniquely placed to help fill the shortages currently faced by the Medical Lab Technology profession," said Rose Elia, Chief Operating Officer of Anderson College.
  • "This partnership represents tremendous value, not only for Anderson College and LifeLabs, but for Ontario's healthcare system as a whole."

LifeLabs shines the spotlight on its employees for the 37th annual National Medical Laboratory Week

Retrieved on: 
Monday, April 11, 2022
Organization, COO, Society, CEO, Health, Medical laboratory scientist, COVID-19, GLOBE, Social media, Collection, Pharmaceutical industry

Toronto, Ontario, April 11, 2022 (GLOBE NEWSWIRE) -- This week marks the 37th annual National Medical Laboratory Week in Canada.

Key Points: 
  • Toronto, Ontario, April 11, 2022 (GLOBE NEWSWIRE) -- This week marks the 37th annual National Medical Laboratory Week in Canada.
  • Organized by the Canadian Society for Medical Laboratory Science , it celebrates the important professionals who work in the medical laboratory industry.
  • National Medical Laboratory Week is one of our favourite events of the year because it truly shines a spotlight on the resilience, dedication, and caring every single one of our team members demonstrates every day.
  • If you would like to thank a medical laboratory professional, let us know on social media on:

PCOM Partners with Havas Health & You on Innovative Research Program

Retrieved on: 
Thursday, April 7, 2022
Lynx, Jewish Healthcare Center (Worcester), Population, Partnership, Leadership, Multimedia, Global health, Research, Forensic medicine, Doctor of Philosophy, Osteopathy, Program, Medical anthropology, JD, Health, HH, View, Industry, Technology, PCOM, Interview, Knowledge, Applied behavior analysis, Medical laboratory scientist, Pharmacy, Osteopathic medicine in the United States, Student, Physician, Strategic planning, Philadelphia, Havas, Education, Health promotion, Management, Medicine, News, Vivendi

The Havas Health & You Research Scholars program, designed specifically for PCOM students, will pair doctor of osteopathic medicine (DO) students with HH&Y mentors who will guide them through the research process.

Key Points: 
  • The Havas Health & You Research Scholars program, designed specifically for PCOM students, will pair doctor of osteopathic medicine (DO) students with HH&Y mentors who will guide them through the research process.
  • If selected for the program, students will work with HH&Y mentors who will facilitate their research efforts.
  • "The HH&Y Research Scholars program is a unique and important opportunity for PCOM students to develop their skills as researchers with a broad focus on global health," said Mindy George-Weinstein, PhD, PCOM's chief research and science officer.
  • Havas Health & You unites Havas Life, Health4Brands (H4B), Lynx,Red Havasand Havas Health Plus, all wholly owned health and communications networks, with the consumer health businesses and practices of Havas Creative Group.

MedShift Continues to Invest in Securing Top Talent to Lead Their Commercial and Technology Business

Retrieved on: 
Thursday, March 31, 2022
GE Healthcare, Business development, Medtech, Leadership, Fat removal procedures, Internet, Software as a service, GE, Deloitte Technology Fast 500, AbbVie, Medical laboratory scientist, Developmental Leadership Program, CEO, Software, Tech, Industry, Technology, SC, Health technology, Surgeon, Machine learning, HIPAA, IOT, Physician, Solution, VP, Soliton, E-commerce, Acquisition, Pharmaceutical industry, Management, Deloitte

CHARLOTTE, N.C., March 31, 2022  /PRNewswire-PRWeb/ -- MedShift, a Charlotte-based Medical Technology company, announces the hiring of two seasoned sales executives Sean Shapiro as Chief Commercial Officer and John Donovan as Business Development & Partnerships leader for MedShift's technology segment.

Key Points: 
  • Having helped lead Soliton as VP of Sales through their commercial launch and completing their $550MM exit to AbbVie created the perfect timing for him to accept his role as Chief Commercial Officer at MedShift.
  • John Donovan, 23-year healthcare industry veteran is very excited to bring his skill set to the MedShift technology portfolio.
  • MedShift adds value across the manufacturer and provider spectrum and continues to empower robust integration with the leading brands and clinicians in the industry.
  • Additionally, in its first year of eligibility, MedShift ranked as the 5th fastest growing medical device business in US in Deloitte's Technology Fast 500.

Fierce Medtech Names Tasso as One of Its “Fierce 15” Med Tech Companies of 2021

Retrieved on: 
Monday, March 7, 2022
Nanotechnology, Pharmaceutical, Research, Software, Medical Devices, Hardware, Hospitals, Data Management, Science, Technology, Practice Management, Nursing, Managed Care, Medical Supplies, Publishing, Biotechnology, Health, Communications, Health, Multimedia, Medical laboratory scientist, Entrepreneurship, Doctor of Philosophy, COVID-19, Technology, Creativity, Face, Investment, CEO, Solution, Research, Industry, Pharmaceutical industry, Accounting, Fierce Medtech, Fierce Medtech, FIERCE MEDTECH

Tasso, Inc., a leader in clinical-grade blood collection technology, today announced that it has been named by Fierce Medtech as one of 2021s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry.

Key Points: 
  • Tasso, Inc., a leader in clinical-grade blood collection technology, today announced that it has been named by Fierce Medtech as one of 2021s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry.
  • To be recognized as one of the 2021 Fierce 15 Med Tech Companies is a tremendous honor and another strong validation of our team and technology.
  • The Fierce 15 celebrates the spirit of being fierce championing innovation and creativity, even in the face of intense competition.
  • Fierce Medtech keeps biopharma executives, device developers, engineers, and researchers updated on the must-know news, trends and developments in medical technology.

Starrag Releases New Machining Center - Bumotec 191neo

Retrieved on: 
Wednesday, March 2, 2022
Medical laboratory scientist, SIX Swiss Exchange, Torque, Industry, Transport, Growth, Maintenance, WMW, Lean manufacturing, PRM, SIP, TTL, Pressure, Aerospace, GLOBE, Machine shop

What could Starrag possibly add to this equipment, already renowned for its reliability, performance and modularity, a solution perfectly suited to the many challenges of machining precise parts with high added value?

Key Points: 
  • What could Starrag possibly add to this equipment, already renowned for its reliability, performance and modularity, a solution perfectly suited to the many challenges of machining precise parts with high added value?
  • By combining all of the expertise inside a truly ergonomic enclosure, they have created the Bumotec 191neo.
  • Amongst other functions, it can be used to monitor the progress of current machining operations, configure the programming, or track production in real time.
  • The umbrella brand Starrag unites the product ranges Berthiez, Bumotec, Drries, Droop+Rein, Ecospeed, Heckert, Scharmann, SIP, Starrag, TTL and WMW.

Starrag USA Inc. Unveils Their New Turbine Blade Machining Center in Their Kentucky Lab

Retrieved on: 
Monday, February 7, 2022
Aerospace, GLOBE, Maintenance, Rigidity, RCS, WMW, Medical laboratory scientist, Transport, Software, TTL, Technology, SPC, SIP, Health, CNC, SIX Swiss Exchange, Haimer, Machine shop, Printed circuit board

HEBRON, Ky., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Starrag USA installs their new LX021 turbine blade machine into their Hebron Kentucky development center to bolster support of their aerospace and energy customers.

Key Points: 
  • HEBRON, Ky., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Starrag USA installs their new LX021 turbine blade machine into their Hebron Kentucky development center to bolster support of their aerospace and energy customers.
  • The turret on the sub-spindle allows multiple work holding strategies to be used to fully machine blades in one setup.
  • The LX021 offers a comprehensive integrated solution that includes:
    Self-centering vice that minimizes part distortion while maintaining accuracy and repeatability.
  • The umbrella brand Starrag unites the product ranges Berthiez, Bumotec, Drries, Droop+Rein, Ecospeed, Heckert, Scharmann, SIP, Starrag, TTL and WMW.

Astrotech Subsidiary BreathTech Hires Dr. Karim Sirgi as Its Chief Science Officer

Retrieved on: 
Wednesday, February 2, 2022
Technology, Research, Medical Devices, Infectious Diseases, Other Technology, Clinical Trials, Biotechnology, Health, Science, Infection, Pneumonia, Leadership, Private Securities Litigation Reform Act, Risk, NASDAQ, MD, Cleveland Clinic, Uncertainty, Volatile organic compound, Research, COVID-19, Corporation, Medical laboratory scientist, Partnership, VOC, Astrotech Corporation, Chief executive officer, School, Annual report, Agriculture, ASTC, Public health, Company, Degenerative disease, FDA, Safe harbor, MBA, Foundation, Mass spectrometry, U.S. Securities and Exchange Commission, Nasdaq, Western Colorado Center for the Arts, Pharmaceutical industry, Medical device, Astrotech, Astrotech Corporation, the BreathTest-1000™, ASTROTECH CORPORATION, THE BREATHTEST-1000™

Astrotech Corporation (Nasdaq: ASTC) has hired Dr. Karim Sirgi, MD, MBA and FCAP as the Chief Science Officer of subsidiary BreathTech Corporation in preparation of human trials with Cleveland Clinic for its BreathTest-1000 to help in the battle against COVID-19 and its variants.

Key Points: 
  • Astrotech Corporation (Nasdaq: ASTC) has hired Dr. Karim Sirgi, MD, MBA and FCAP as the Chief Science Officer of subsidiary BreathTech Corporation in preparation of human trials with Cleveland Clinic for its BreathTest-1000 to help in the battle against COVID-19 and its variants.
  • As we look to kick-off our human trials with Cleveland Clinic, we are excited to have Dr. Sirgi join the team to help oversee the effort, said Thomas B. Pickens, Chairman and Chief Executive Office of both BreathTech Corporation and Astrotech Corporation, the parent company of BreathTech.
  • Dr. Sirgi has deep industry experience to help lead the research and development efforts at BreathTech as we look to commercialize a fast and non-invasive screening device to aid in the battle against COVID-19.
  • I am excited to join the team and to help oversee the efforts through to commercialization, stated Dr. Sirgi.